#United States #Denver #Kidney Care #DaVita #CKCC

DaVita's Progress in Value-Based Kidney Care

DaVita, a leading healthcare provider known for its innovative kidney care solutions, has recently showcased its continued advancements in value-based kidney care. As they highlight the achievements resulting from sustained investments in coordinated care models, it becomes evident that these efforts are producing noteworthy improvements for individuals grappling with kidney disease.

A Focus on Coordinated Care

For over two decades, DaVita has dedicated resources to transforming the experience for patients living with kidney disease. By embracing value-based care models, the organization aims to facilitate a more comprehensive and continuous support system rather than relying solely on episodic treatments. This approach not only enhances patient engagement but also significantly improves clinical outcomes.

The results from the Comprehensive Kidney Care Contracting (CKCC) option, under the Center for Medicare and Medicaid Innovation (CMMI), epitomize this success. As one of the largest ongoing federal demonstrations in value-based kidney care, CKCC allows healthcare providers to refine and implement coordinated care methods on a scalable level. The latest performance results reveal consistent year-over-year advancements, underscoring DaVita's momentum as it builds upon these models.

Documented Improvements

Recent data reflecting performance through 2024 indicates substantial strides made by DaVita and its affiliated healthcare teams:

• - Enhanced Quality Outcomes: DaVita achieved a remarkable 9% improvement in its Total Quality Score. This uplift is attributed to better patient activation, optimal treatment starts, and increased support for behavioral health.
• - Significant Shared Savings: Since the inception of CKCC, DaVita has generated over $200 million in shared savings, demonstrating the economic benefits of value-based care.
• - Recognition as High Performers: DaVita and its affiliated physicians made a notable impact, comprising 34% of the High Performers Pool, while only representing 28% of the participating providers.

These metrics go beyond simple numbers; they correlate with meaningful enhancements in clinical quality and overall public health outcomes.

Patients benefiting from CKCC and similar value-based care initiatives are more likely to:

• - Begin kidney replacement therapy with adequately planned treatments, with increased utilization of home-based options.
• - Experience reduced rates of central venous catheter usage, promoting safer patient treatment initiation.
• - Miss fewer treatments due to improved engagement and coordination among care teams.

Dr. Jeff Giullian, Chief Medical Officer at DaVita, remarked on the importance of collaboration, stating, "Individuals dealing with kidney disease often manage concurrent chronic conditions. Achieving strong outcomes necessitates close teamwork across the healthcare landscape. Value-based models like CKCC empower us to enhance care coordination beyond kidney disease, fostering a shared vision that leads to timely interventions and informed decision-making regarding treatments and transplant options."

A Commitment to Long-Term Value-Based Care

DaVita's engagement with value-based care models stretches back more than two decades, and it currently manages upwards of $5 billion in medical costs. These models not only lead to elevated transplant rates but also empower patients to better understand their health conditions, facilitating proactive and informed choices.

Misha Palecek, DaVita’s Chief Transformation Officer, observed, "The progress we’re witnessing in value-based kidney care demonstrates the potential that arises when healthcare providers commit time and resources to coordinated care frameworks. We're beginning to see better-prepared patients, improved experiences, and favorable economic trends that align with our goals. The insights gained from managing kidney care can extend to other complex chronic conditions, influencing the broader healthcare system positively."

Early Signs of Innovation in Kidney Care

DaVita's advancements in integrated kidney care signify not only better patient outcomes but also emerging financial sustainability, which reflects the potential impact of their healthcare delivery models. These developments reinforce the idea that a sustained focus on improving kidney care can lead to transformative changes across healthcare sectors, with coordinated models paving the way for lasting innovation and accountability.

To learn more about DaVita's initiatives in value-based kidney care, visit DaVita.com/IKC.

Conclusion

For more than 25 years, DaVita has emerged as a frontrunner in both clinical quality and innovation within the domain of kidney care. The firm is dedicated to enhancing the lives of patients at all stages of their kidney health journey, fostering effective solutions both at home and in various healthcare settings. As of now, DaVita supports approximately 295,000 patients at over 3,200 outpatient dialysis centers across the globe.

Through ongoing improvement and innovation, DaVita remains committed to delivering high-quality care and effective solutions to those in need of kidney care services, setting the standard for excellence in the industry.